China lab seeks patent on use of Gilead's coronavirus treatment
BEIJING/SHANGHAI (Reuters) - A state-run Chinese research institute has applied for a patent on the use of Gilead Sciences’ experimental U.S. antiviral drug, which scientists think could provide treat